Clinical Trial Update: Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tafoxiparin for primary slow labor progression, including prolonged latent phase and labor arrest, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Labor Obstetric

Drugs mentioned

• Tafoxiparin (tafoxiparin)

Snippet

Sponsor: Dilafor AB | Conditions: Labor, Obstetric | Phase 2 | Status: COMPLETED